Jump to content
Digitalizing Biopharma R&D | Genedata

Digitalizing
Biopharma R&D

The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D.

Discover Our Platform

Our Customers

Since its founding in 1997, Genedata has been supporting the transformation of biopharma R&D. Today, the Genedata Biopharma Platform digitalizes biopharmaceutical R&D processes, streamlining the entire R&D workflow to increase throughput and improve data quality.

Missed the 2024 Biopharma
Partner Symposium?

Watch this short summary of highlights of the 10th annual Genedata Biopharma Partner Symposium.

More than 250 people attended from companies including Pfizer, Novartis, AstraZeneca, AbbVie, GSK, Bayer, Janssen, Merck, Sanofi, Boehringer Ingelheim, Amgen, Gilead, Roche, Daiichi Sankyo, Novo Nordisk, UCB, Servier, Ferring, together with renowned biotechs including Genmab, Bicycle Therapeutics, Immatics, as well as CROs and CDMOs such as Sartorius, Sandoz, Novozymes, and Charles River.

Enabling Automation of Complex R&D Processes | Genedata

Purpose-Built. Proven.

Relied on by global biopharma giants and cutting-edge biotechs, the Genedata Biopharma Platform helps organizations to significantly reduce costs, accelerate workflows and improve overall productivity.

The Genedata Biopharma Platform enables automation of complex R&D processes for any therapeutic format and modality.

The Next-Gen R&D Platform | Genedata

Unique. Game-Changing.

Unlike traditional electronic lab notebooks (ELNs) or laboratory information management systems (LIMS), the Genedata Biopharma Platform is a next-generation platform that drives process efficiency and innovation by integrating R&D workflows, automating R&D operations, eliminating bottlenecks, and fostering collaboration.

With built-in business logic and an open architecture, it simplifies daily work, leverages results on a corporate scale, and empowers the establishment of novel R&D technologies and workflows.

The Next Level of Artificial Intelligence | Genedata

AI Ready.

New robotic systems and laboratory automation have dramatically increased the amount of experimental data for capture, processing, and analysis. Only a truly scalable platform can manage the exponentially growing volume of data, which fuels next-generation artificial intelligence (AI) and machine learning (ML) technologies.

AI approaches such as Deep Learning require systematic access to structured data to extract patterns to guide future R&D projects. Unstructured data repositories, even when centralized, make it impossible to make sense out of the data. Only a fully integrated data infrastructure can transform R&D operations.

AI is here. Are you ready?

Services | Genedata

Transformative. Our Services.

Genedata offers a variety of consulting and professional services to complement our Genedata Biopharma Platform. These services facilitate optimal setup and usage of the platform, easily adopting best practices—on premises or as Software as a Service (SaaS).

Learn More About Our Services

Smart Technologies. Smarter Processes.

Learn More About Our Products